NEUROTOXICITY OF HALLUCINOGENIC SUBSTITUTED AMPHETAMINES
NEUROTOXICITY OF HALLUCINOGENIC SUBSTITUTED AMPHETAMINES
批准号:
3210055
负责人:
MARK E MOLLIVER
金额:
$14.67万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1987
资助国家:
美国
项目状态:
已结题
起止时间:
1987-07-01 至 1990-06-30
关键词:
amphetamines axon biotransformation blood brain barrier central nervous system dosage drug administration routes fenfluramine high performance liquid chromatography histochemistry /cytochemistry liver metabolism microinjections microsomes nervous system regeneration neural degeneration neuronal transport neuropharmacology neurotoxins neurotransmitters psychotomimetic drug serotonin tissue /cell culture
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The goals of this project are to characterize the neurotoxic effects of
substituted amphetamines (MDA and MDMA) upon CNS monoaminergic neurons.
The hypothesis will be tested that the toxic effects of these drugs are due
to the formation of a hepatic metabolite. The potential for regenerative
sprouting and recovery of damaged serotonin axons will be determined. A
method will be developed to test the toxicity of metabolites derived from
hepatic microsomal incubations. 1) To characterize the neurotoxic effects,
immunocytochemistry will be used to visualize degenerating and spared
monoamine axons; changes in neurotransmitter levels will be determined by
HPLC. Different doses will be studied to determine the dose-response curve
and to identify the specific neuronal compartment damaged. Regional
effects will be studied in forebrain, brainstem and spinal cord to
determine the specificity of the toxic effect on serotonin axons and to
identify raphe cell groups and axon types that may be spared. The cells of
origin of damaged versus spared serotonin axons will be identified by
axonal transport methods. The results obtained from the rat will be used
to guide similar studies of neurotoxicity in primates. 2) It is essential
to resolve whether the neurotoxic effects of systemic MDA are due to a
metabolite or may be secondary to hyperthermia or cardiovascular changes.
To show that the parent compound is not directly neurotoxic, sustained
intracerebral doses of the drugs will be administered by a chronic
implanted cannula and minipump. 3) To study the potential for sprouting
and recovery of damaged axons, immunocytochemistry and HPLC will be done
following long survivals; axon transport methods will be used to determine
which cell groups give rise to regenerating axons. 4) Identification of
the toxic class of metabolites will be attempted by intracerebral
microinjection of extracts from hepatic microsomal incubations of the
drugs. These studies should characterize the mechanism, conditions, and
specificity of neurotoxicity caused by substituted amphetamines that have
become widely used as drugs of abuse. Moreover, if safe conditions and
doses can be identified, these drugs may be useful in psychotherapy.
Because of widespread abuse among college and professional groups, these
drugs constitute a major and serious health hazard to young Americans;
their dramatic neurotoxicity needs to be established definitively and
publicized educationally.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DRUG ADDICTION: DUAL 5-HT INNERVATION OF LIMBIC SYSTEM
-
批准号:6603955
-
项目类别:
-
资助金额:$32.7万
-
财政年份:2001
-
负责人:MARK E MOLLIVER
-
依托单位:
DRUG ADDICTION: DUAL 5-HT INNERVATION OF LIMBIC SYSTEM
-
批准号:6515824
-
项目类别:
-
资助金额:$32.7万
-
财政年份:2001
-
负责人:MARK E MOLLIVER
-
依托单位:
DRUG ADDICTION: DUAL 5-HT INNERVATION OF LIMBIC SYSTEM
-
批准号:6404210
-
项目类别:
-
资助金额:$32.7万
-
财政年份:2001
-
负责人:MARK E MOLLIVER
-
依托单位:
MECHANISM OF IBOGAINE INDUCED PURKINJE CELL DEGENERATION
-
批准号:2121349
-
项目类别:
-
资助金额:$30.72万
-
财政年份:1994
-
负责人:MARK E MOLLIVER
-
依托单位:
MECHANISM OF IBOGAINE INDUCED PURKINJE CELL DEGENERATION
-
批准号:2121350
-
项目类别:
-
资助金额:$31.13万
-
财政年份:1994
-
负责人:MARK E MOLLIVER
-
依托单位:
MECHANISM OF IBOGAINE INDUCED PURKINJE CELL DEGENERATION
-
批准号:2733535
-
项目类别:
-
资助金额:$35.02万
-
财政年份:1994
-
负责人:MARK E MOLLIVER
-
依托单位:
MECHANISM OF IBOGAINE INDUCED PURKINJE CELL DEGENERATION
-
批准号:2121351
-
项目类别:
-
资助金额:$32.38万
-
财政年份:1994
-
负责人:MARK E MOLLIVER
-
依托单位:
MECHANISM OF IBOGAINE INDUCED PURKINJE CELL DEGENERATION
-
批准号:2443470
-
项目类别:
-
资助金额:$33.67万
-
财政年份:1994
-
负责人:MARK E MOLLIVER
-
依托单位:
NEUROTOXICITY SCREENING
-
批准号:2306318
-
项目类别:
-
资助金额:$46.54万
-
财政年份:1993
-
负责人:MARK E MOLLIVER
-
依托单位:
NEUROTOXICITY SCREENING
-
批准号:2306320
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1993
-
负责人:MARK E MOLLIVER
-
依托单位:
NEUROTOXICITY SCREENING
-
批准号:2625795
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1993
-
负责人:MARK E MOLLIVER
-
依托单位:
NEUROTOXICITY SCREENING
-
批准号:2306319
-
项目类别:
-
资助金额:$65.62万
-
财政年份:1993
-
负责人:MARK E MOLLIVER
-
依托单位:
NEUROTOXICITY SCREENING
-
批准号:2306317
-
项目类别:
-
资助金额:$80.7万
-
财政年份:1993
-
负责人:MARK E MOLLIVER
-
依托单位:
NEUROTOXIC EFFECTS OF DRUGS ON SEROTONERGIC NEURONS
-
批准号:3210056
-
项目类别:
-
资助金额:$18.78万
-
财政年份:1987
-
负责人:MARK E MOLLIVER
-
依托单位:
NEUROTOXICITY OF HALLUCINOGENIC SUBSTITUTED AMPHETAMINES
-
批准号:3210058
-
项目类别:
-
资助金额:$16.99万
-
财政年份:1987
-
负责人:MARK E MOLLIVER
-
依托单位:
NEUROTOXICITY OF HALLUCINOGENIC SUBSTITUTED AMPHETAMINES
-
批准号:3210057
-
项目类别:
-
资助金额:$14.77万
-
财政年份:1987
-
负责人:MARK E MOLLIVER
-
依托单位:
NEUROTOXIC EFFECTS OF DRUGS ON SEROTONERGIC NEURONS
-
批准号:3210059
-
项目类别:
-
资助金额:$20.65万
-
财政年份:1987
-
负责人:MARK E MOLLIVER
-
依托单位:
NEUROTOXIC EFFECTS OF DRUGS ON SEROTONERGIC NEURONS
-
批准号:2117193
-
项目类别:
-
资助金额:$22.83万
-
财政年份:1987
-
负责人:MARK E MOLLIVER
-
依托单位:
NEUROTOXIC EFFECTS OF DRUGS ON SEROTONERGIC NEURONS
-
批准号:3210060
-
项目类别:
-
资助金额:$21.24万
-
财政年份:1987
-
负责人:MARK E MOLLIVER
-
依托单位:
NEUROTOXIC EFFECTS OF DRUGS ON SEROTONERGIC NEURONS
-
批准号:3210061
-
项目类别:
-
资助金额:$20.92万
-
财政年份:1987
-
负责人:MARK E MOLLIVER
-
依托单位:
海外基金